ACADIA Pharmaceuticals Inc: Stock Chart
ACADIA Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of small molecule drugs that address unmet medical needs in neurological and related central nervous system disorders. Its lead product candidate is NUPLAZID, which completed the Phase III pivotal trials for the treatment of Parkinson’s disease psychosis; is in Phase II study for Alzheimer’s disease psychosis; and has completed Phase II trial for the treatment of schizophrenia. It also has clinical-stage programs for chronic pain and glaucoma in collaboration with Allergan, Inc. ACADIA Pharmaceuticals Inc. was founded in 1993 and is headquartered in San Diego, California.
Sector & Industry Watch List
Symbol | Name | Purchase price | Last Price | Change | % Change |
---|---|---|---|---|---|
0.00 | |||||
Symbol | Name | Last Price | Change | % Change |
---|---|---|---|---|